Consejo Superior de Investigaciones Cientificas:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Consejo Superior de Investigaciones Cientificas - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9404
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Consejo Superior de Investigaciones Cientificas (CSIC) is a research institute that offers research capacity, and human and material resources to conduct research projects. The institute offers multidisciplinary scientific and technical research, scientific and technical advice, management of infrastructures and large facilities, and others. Its scientific areas include humanities and social sciences, biology and biomedicine, natural resources, agricultural sciences, physical science and technologies, materials science and technology, food science and technology, and chemical science and technology. The institute also offers research training, post graduate courses, and predoctoral contracts. CSIC is headquartered in Madrid, Spain.

Consejo Superior de Investigaciones Cientificas – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Inmunotek Enters into Agreement with CIB-CSIC 10
Licensing Agreements 11
Evgen Pharma Exercises Option for Licensing Agreement with CSIC and University of Seville 11
Janus Developments Enters Into Licensing Agreement With UB, CSIC And UAB 12
HIVACAT Enters into Licensing Agreement with CSIC 13
Consejo Superior de Investigaciones Cientificas – Key Competitors 14
Consejo Superior de Investigaciones Cientificas – Key Employees 15
Consejo Superior de Investigaciones Cientificas – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Government and Public Interest 17
Nov 17, 2017: Researchers of the CSIC discover that a group of lymphocytes activates a response capable of destroying tumors 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Key Facts 2
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Consejo Superior de Investigaciones Cientificas, Deals By Therapy Area, 2012 to YTD 2018 8
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Inmunotek Enters into Agreement with CIB-CSIC 10
Evgen Pharma Exercises Option for Licensing Agreement with CSIC and University of Seville 11
Janus Developments Enters Into Licensing Agreement With UB, CSIC And UAB 12
HIVACAT Enters into Licensing Agreement with CSIC 13
Consejo Superior de Investigaciones Cientificas, Key Competitors 14
Consejo Superior de Investigaciones Cientificas, Key Employees 15

List of Figures
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Consejo Superior de Investigaciones Cientificas:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Turboatom (TATM):企業の財務・戦略的SWOT分析
    Turboatom (TATM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Alphanosos SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Alphanosos SAS (Alphanosos) is a developer of novel therapies for the treatment of chronic inflammatory diseases. The company offers pure antibiofilms and antibiotics. It concentrates on bacterial biofilms in various therapeutic areas such as dermatological, bucco-dental and respiratory dise …
  • Revance Therapeutics Inc (RVNC):企業の財務・戦略的SWOT分析
    Revance Therapeutics Inc (RVNC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Amsted Industries Inc:企業の戦略・SWOT・財務分析
    Amsted Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Amsted Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Xi’An Catering Co., Ltd.
    Xi'An Catering Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Xi'An Catering Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • MSC Crociere S.A.:企業の戦略・SWOT・財務情報
    MSC Crociere S.A. - Strategy, SWOT and Corporate Finance Report Summary MSC Crociere S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Exchange Income Corporation:企業の戦略・SWOT・財務分析
    Exchange Income Corporation - Strategy, SWOT and Corporate Finance Report Summary Exchange Income Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • MagForce AG (MF6):企業の財務・戦略的SWOT分析
    Summary MagForce AG (MagForce) is a medical device company that offers nanotechnology-based therapy for cancer treatment. The company’s products include NanoActivator, NanoTherm, NanoPlan and NanoTherm Therapy. Its NanoActivator creates a magnetic field that can be used to treat tumors in all areas …
  • Indianapolis Power & Light Co:企業の戦略的SWOT分析
    Indianapolis Power & Light Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Advanced Medical Electronics Corp:製品パイプライン分析
    Summary Advanced Medical Electronics Corp (AME) is a medical device company that offers research and development services. The company provides electrocardiograph and spirometer equipment. It provides battery powered surgical headlamp, oximeter, partial polysomnograph, and computerized visual acuity …
  • ContraVir Pharmaceuticals Inc (CTRV):製薬・医療:M&Aディール及び事業提携情報
    Summary ContraVir Pharmaceuticals Inc (ContraVir) is a biopharmaceutical company that offers development and commercialization of targeted antiviral therapies. The company provides pipeline product such as TXL, potent prodrug of antiviral tenofovir and CRV431 cyclophilin inhibitor that increases its …
  • Nintendo Co Ltd (7974):企業の財務・戦略的SWOT分析
    Nintendo Co Ltd (7974) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • The Hartford Financial Services Group, Inc.:企業の戦略・SWOT・財務情報
    The Hartford Financial Services Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Hartford Financial Services Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • PT Dahana:企業の戦略・SWOT・財務情報
    PT Dahana - Strategy, SWOT and Corporate Finance Report Summary PT Dahana - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Itamar Medical Ltd (ITMR):医療機器:M&Aディール及び事業提携情報
    Summary Itamar Medical Ltd (Itamar Medical) is a medical device company that develops, markets and sells diagnostic medical devices for the diagnosis and treatment of sleep apnea. The company’s products include EndoPAT, a medical device for the diagnosis of endothelial dysfunction assessment tool fo …
  • Paymark:企業の戦略的SWOT分析
    Paymark - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Fonterra Co-operative Group Ltd:企業のM&A・事業提携・投資動向
    Fonterra Co-operative Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fonterra Co-operative Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • CVS Health Corporation:企業のM&A・事業提携・投資動向
    CVS Health Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CVS Health Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Datron World Communications, Inc.:企業の戦略・SWOT・財務情報
    Datron World Communications, Inc. - Strategy, SWOT and Corporate Finance Report Summary Datron World Communications, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Glaukos Corp (GKOS):医療機器:M&Aディール及び事業提携情報
    Summary Glaukos Corp (Glaukos) is an ophthalmic medical device company that research and develops micro technologies to improve glaucoma therapy. The company develops injectable micro-scale therapies to address the complete range of glaucoma disease states and progression. It provides products such …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆